82
Participants
Start Date
September 30, 2009
Primary Completion Date
May 31, 2010
Study Completion Date
August 31, 2010
Tapentadol PR
"Tapentadol Prolonged Release (PR) Titration and Optimal Dose Period: Starting at 50 mg, 100 mg or 150 mg Tapentadol PR twice daily, adjusting at 50 mg PR steps (upwards or downwards) as necessary to achieve a balance between pain relief and a satisfactory level of tolerability. Participants were not permitted to exceed 500 mg of Tapentadol per day.~Maintenance Period: Participants continuing on the dose established in the previous period."
Site 4, Melbourne
Site 2, Perth
Site 4, Aalborg
Site 7, Hvidovre
Site 6, Kolding
Site 2, Odense
Site 3, Vejle
Site 1, Berlin
Site 7, Katzhütte
Site 2, Leer
Site 8, Leipzig
Site 9, Zerbst
Site 4, Lublin
Site 5, Ostrów Mazowiecka
Site 2, Tychy
Site 4, Madrid
Site 1, Valencia
Site 3, Birmingham
Site 6, Carmarthen
Site 1, Leeds
Site 2, London
Site 8, Middlesbrough
Site 9, Oxford
Site 10, York
Lead Sponsor
Grünenthal GmbH
INDUSTRY